by Kayla Giacin | Jun 4, 2021 | Latest News
As we all know, there continues to be a dire need for new treatment options for diffuse midline gliomas #DMG A breakthrough in recent years have shown that many DMGs have a specific K27M mutation on Histone protein H3. What are histones? Histones bind, unwrap or...
by Kayla Giacin | Apr 16, 2021 | Latest News
– Chia-Yi, Hou Changing America Glioblastoma is a type of cancer that can form in the brain or spinal cord. The drugs used in the clinical trial are atezolizumab, an immunotherapy drug, and ipatasertib, a new precision drug that “may be able to uncloak tumours...
by Kayla Giacin | Apr 2, 2021 | Latest News
-MORNING EDITION, NPR NEWS Lots of people have questions about getting vaccinated against COVID-19. That includes the millions of Americans with weakened immune systems that put them at higher risk of severe disease if they do get infected with the coronavirus....
by Kayla Giacin | Mar 29, 2021 | Latest News
Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patient’s immune system to these mutated proteins. For the first time, physicians and cancer...
by Kayla Giacin | Mar 19, 2021 | Latest News
Summary Background Cisplatin is used to treat a wide range of childhood cancers and cisplatin-induced hearing loss (CIHL) is a common and debilitating toxicity. We aimed to address persistent knowledge gaps in CIHL by establishing benchmarks for the prevalence of and...
by Kayla Giacin | Jan 13, 2021 | Latest News
MINNEAPOLIS (WCCO) — The University of Minnesota on Thursday announced that a promising new brain cancer clinical trial is underway. It’s Phase I of the first-in-human trial, and university physicians and scientists are enrolling patients with glioblastoma, which is...
